PAK6 increase chemoresistance and is a prognostic marker for stage II and III colon cancer patients undergoing 5-FU based chemotherapy

Jian Chen(Wenzhou Medical University), Zhihai Peng(Shanghai Jiao Tong University)
Oncotarget
November 7, 2014
Cited by 46


Related Papers